ANAVEX LIFE SCIENCES CORP. Other General and Administrative Expense
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Other General and Administrative Expense of $713.50 thousand for the 3-month period ending 2015-06-30, per its 10-Q filed 2015-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherGeneralAndAdministrativeExpense · last filed 2015-08-14
- ANAVEX LIFE SCIENCES CORP. other general and administrative expense for the quarter ending 2015-06-30 was $713.50K, a 2.77% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. other general and administrative expense for the quarter ending 2015-03-31 was $451.19K, a 50.03% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. other general and administrative expense for the quarter ending 2014-12-31 was $452.05K, a 48.49% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. other general and administrative expense for the quarter ending 2014-09-30 was $295.32K, a 78.46% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. other general and administrative expense for fiscal 2014 was $2.24M, a 19.38% increase from fiscal 2013.
- ANAVEX LIFE SCIENCES CORP. other general and administrative expense for fiscal 2013 was $1.87M, a 20382.34% increase from fiscal 2012.
- ANAVEX LIFE SCIENCES CORP. other general and administrative expense for fiscal 2012 was $9.15K, a 69.58% decline from fiscal 2011.
- ANAVEX LIFE SCIENCES CORP. other general and administrative expense for fiscal 2011 was $30.07K, a 24.30% decline from fiscal 2010.
| Period end | Other General and Administrative Expense 3 month | Other General and Administrative Expense 3 month as first filed | Other General and Administrative Expense 6 month | Other General and Administrative Expense 6 month as first filed | Other General and Administrative Expense 9 month | Other General and Administrative Expense 9 month as first filed | Other General and Administrative Expense 12 month | Other General and Administrative Expense 12 month as first filed | Other General and Administrative Expense 89 month | Other General and Administrative Expense 92 month | Other General and Administrative Expense 95 month | Other General and Administrative Expense 98 month | Other General and Administrative Expense 101 month | Other General and Administrative Expense 104 month | Other General and Administrative Expense 107 month | Other General and Administrative Expense 110 month | Other General and Administrative Expense 113 month | Other General and Administrative Expense 116 month | Other General and Administrative Expense 119 month | Other General and Administrative Expense 122 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-06-30 | $713.50K 10-Q · filed 2015-08-14 | $1.16M derived: sum of 2 quarters · filed 2015-08-14 | $1.62M 10-Q · filed 2015-08-14 | $1.91M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2015-03-31 | $451.19K 10-Q · filed 2015-05-14 | $903.25K 10-Q · filed 2015-05-14 | $1.20M derived: sum of 3 quarters · filed 2015-05-14 | $1.93M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2014-12-31 | $452.05K 10-Q · filed 2015-02-17 | $747.37K derived: sum of 2 quarters · filed 2015-02-17 | $1.48M derived: sum of 3 quarters · filed 2015-08-14 | $2.38M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2014-09-30 | $295.32K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $1.03M derived: sum of 2 quarters · filed 2015-08-14 | $1.93M derived: sum of 3 quarters · filed 2015-08-14 | $2.24M 10-K · filed 2014-12-29 | ||||||||||||||||
| 2014-06-30 | $733.82K 10-Q · filed 2015-08-14 | $1.64M derived: sum of 2 quarters · filed 2015-08-14 | $1.94M 10-Q · filed 2015-08-14 | $3.31M derived: sum of 4 quarters · filed 2015-08-14 | ||||||||||||||||
| 2014-03-31 | $903.01K 10-Q · filed 2015-05-14 | $1.21M 10-Q · filed 2015-05-14 | $2.58M derived: sum of 3 quarters · filed 2015-05-14 | $2.67M derived: sum of 4 quarters · filed 2015-05-14 | $18.41M 10-Q/A · filed 2014-05-30 | |||||||||||||||
| 2013-12-31 | $304.43K 10-Q · filed 2015-02-17 | $2.31K 10-Q · filed 2014-02-14 | $1.68M derived: sum of 2 quarters · filed 2015-02-17 | $1.76M derived: sum of 3 quarters · filed 2015-02-17 | $1.89M derived: sum of 4 quarters · filed 2015-02-17 | $154.01K 10-Q · filed 2014-02-14 | ||||||||||||||
| 2013-09-30 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-29 | $1.46M derived: sum of 2 quarters · filed 2014-12-29 | $1.58M derived: sum of 3 quarters · filed 2014-12-29 | $1.87M 10-K · filed 2014-12-29 | $4.02K 10-K · filed 2013-12-30 | $151.70K 10-K · filed 2013-12-30 | ||||||||||||||
| 2013-06-30 | $86.96K 10-Q · filed 2014-08-13 | $295.00 10-Q · filed 2013-08-14 | $213.51K derived: sum of 2 quarters · filed 2014-08-13 | $502.38K 10-Q · filed 2014-08-13 | $407.00 10-Q · filed 2013-08-14 | $214.24K derived: sum of 4 quarters · filed 2014-08-13 | $148.09K 10-Q · filed 2013-08-14 | |||||||||||||
| 2013-03-31 | $126.55K 10-Q/A · filed 2014-05-30 | $112.00 10-Q · filed 2013-05-17 | $415.42K 10-Q/A · filed 2014-05-30 | $112.00 10-Q · filed 2013-05-17 | $127.28K derived: sum of 3 quarters · filed 2014-05-30 | $130.24K derived: sum of 4 quarters · filed 2014-05-30 | $147.80K 10-Q · filed 2013-05-17 | |||||||||||||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-14 | $727.00 derived: sum of 2 quarters · filed 2014-02-14 | $3.69K derived: sum of 3 quarters · filed 2014-02-14 | $5.97K derived: sum of 4 quarters · filed 2014-02-14 | $147.68K 10-Q · filed 2013-02-14 | |||||||||||||||
| 2012-09-30 | $727.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-30 | $3.69K derived: sum of 2 quarters · filed 2013-12-30 | $5.97K derived: sum of 3 quarters · filed 2013-12-30 | $9.15K 10-K · filed 2013-12-30 | $147.68K 10-K · filed 2012-12-31 | |||||||||||||||
| 2012-06-30 | $2.96K 10-Q · filed 2013-08-14 | $5.25K derived: sum of 2 quarters · filed 2013-08-14 | $8.42K 10-Q · filed 2013-08-14 | $13.87K derived: sum of 4 quarters · filed 2013-08-14 | $146.96K 10-Q · filed 2012-08-17 | |||||||||||||||
| 2012-03-31 | $2.28K 10-Q · filed 2013-05-17 | $5.46K 10-Q · filed 2013-05-17 | $10.91K derived: sum of 3 quarters · filed 2013-05-17 | $15.90K derived: sum of 4 quarters · filed 2013-05-17 | $143.99K 10-Q · filed 2012-05-15 | |||||||||||||||
| 2011-12-31 | $3.17K 10-Q · filed 2013-02-14 | $8.63K derived: sum of 2 quarters · filed 2013-02-14 | $13.62K derived: sum of 3 quarters · filed 2013-02-14 | $26.77K derived: sum of 4 quarters · filed 2013-02-14 | $141.71K 10-Q · filed 2012-02-14 | |||||||||||||||
| 2011-09-30 | $5.45K derived: 10-K 12 month − 10-Q 9 month · filed 2012-12-31 | $10.45K derived: sum of 2 quarters · filed 2012-12-31 | $23.60K derived: sum of 3 quarters · filed 2012-12-31 | $30.07K 10-K · filed 2012-12-31 | $138.54K 10-K · filed 2011-12-22 | |||||||||||||||
| 2011-06-30 | $5.00K 10-Q · filed 2012-08-17 | $18.15K derived: sum of 2 quarters · filed 2012-08-17 | $24.61K 10-Q · filed 2012-08-17 | -$121.06K derived: sum of 4 quarters · filed 2012-08-17 | $133.08K 10-Q · filed 2011-08-12 | |||||||||||||||
| 2011-03-31 | $13.15K 10-Q · filed 2012-05-15 | $19.62K 10-Q · filed 2012-05-15 | -$126.06K derived: sum of 3 quarters · filed 2012-05-15 | -$42.79K derived: sum of 4 quarters · filed 2012-05-15 | ||||||||||||||||
| 2010-12-31 | $6.47K 10-Q · filed 2012-02-14 | -$139.21K derived: sum of 2 quarters · filed 2012-02-14 | -$55.94K derived: sum of 3 quarters · filed 2012-02-14 | |||||||||||||||||
| 2010-09-30 | -$145.68K derived: 10-K 12 month − 10-Q 9 month · filed 2011-12-22 | -$62.41K derived: sum of 2 quarters · filed 2011-12-22 | $39.72K 10-K · filed 2011-12-22 | |||||||||||||||||
| 2010-06-30 | $83.27K 10-Q · filed 2011-08-12 | $185.40K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |